VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL

被引：0
|
作者：
Rittmaster, R. [1 ]
Aubin, S. M. J. [2 ]
Reid, J. [2 ]
Sarno, M. J. [2 ]
Blase, A. [2 ]
Aussie, J. [2 ]
Rittenhouse, H. [2 ]
Andriole, G. L. [3 ]
Groskopf, J. [2 ]
机构：
[1] GlaxoSmithKline Inc, Oncol Clin Dev & Med Affairs, Res Triangle Pk, NC USA
[2] Gen Probe Inc, Dept Oncol, San Diego, CA USA
[3] Washington Univ, Sch Med, Barnes Jewish Hosp, St Louis, MO USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60954-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL
    Marks, Leonard
    Aubin, Sheila
    Reid, Jennifer
    Sarno, Mark
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Andriole, Gerald
    Rittmaster, Roger
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2010, 183 (04): : E823 - E823
  • [2] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial
    Aubin, Sheila M. J.
    Reid, Jennifer
    Sarno, Mark J.
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger
    Andriole, Gerald L.
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2010, 184 (05): : 1947 - 1952
  • [3] PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial EDITORIAL COMMENT
    Vlaeminck-Guillem, Virginie
    JOURNAL OF UROLOGY, 2010, 184 (05): : 1952 - 1952
  • [4] PCA3: A molecular urine assay for predicting prostate biopsy outcome
    Deras, Ina L.
    Aubin, Sheila M. J.
    Blase, Amy
    Day, John R.
    Koo, Seongjoon
    Partin, Alan W.
    Ellis, William J.
    Marks, Leonard S.
    Fradet, Yves
    Rittenhouse, Harry
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2008, 179 (04): : 1587 - 1592
  • [5] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL
    Andriole, Gerald
    Aubin, Sheila
    Reid, Jennifer
    Sarno, Mark
    Blase, Amy
    Aussie, Jacqueline
    Rittenhouse, Harry
    Rittmaster, Roger
    Groskopf, Jack
    JOURNAL OF UROLOGY, 2010, 183 (04): : E801 - E801
  • [6] PCA3 PREDICTS PROSTATE BIOPSY OUTCOME IN MEN RECEIVING DUTASTERIDE: RESULTS FROM THE DUTASTERIDE REDUCE TRIAL
    Andriole, G.
    Aubin, S. M. J.
    Reid, J.
    Samo, M. J.
    Blase, A.
    Aussie, J.
    Rittenhouse, H.
    Roger, R.
    Groskopf, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 306 - 306
  • [7] PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy
    Marks, Leonard S.
    Fradet, Yves
    Deras, Ina Lim
    Blase, Amy
    Mathis, Jeannette
    Aubin, Sheila M. J.
    Cancio, Anthony T.
    Desaulniers, Marie
    Ellis, William J.
    Rittenhouse, Harry
    Groskopf, Jack
    UROLOGY, 2007, 69 (03) : 532 - 535
  • [8] PCA3: A molecular urine prostate cancer test
    Rittenhouse, Harry
    TUMOR BIOLOGY, 2007, 28 : 50 - 50
  • [9] PCA3 Molecular Urine Assay Pivotal US Clinical Study Confirms Utility for Predicting Repeat Biopsy Outcome
    Groskopf, J.
    Ward, J.
    Hertzman, B.
    Bailen, J.
    Franco, N.
    Williams, T.
    Koziol, I
    Henderson, J.
    Bidair, M.
    Gittelman, M.
    UROLOGY, 2012, 80 (03) : S30 - S31
  • [10] PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
    Gittelman, Marc C.
    Hertzman, Bernard
    Bailen, James
    Williams, Thomas
    Koziol, Isaac
    Henderson, Ralph Jonathan
    Efros, Mitchell
    Bidair, Mohamed
    Ward, John F.
    JOURNAL OF UROLOGY, 2013, 190 (01): : 64 - 69
12345